ReviewCurrent treatment options in oncology2019

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Laurent Mhanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.